Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Researchers will test Pfizer pipeline to find treatments for some tropical illnesses
Yahoo/AP
Wednesday, November 18, 2009 - 12:13pm
tags:
Pfizer, partnerships
GSK Takes Dow Jones to Task - on Its Blog
BNET Pharma
Wednesday, November 18, 2009 - 10:18am
tags:
GSK, Dow Jones, Teva Pharmaceuticals, Promacta
Good News for Alkermes' Pipeline
Yahoo/Zacks.com
Wednesday, November 18, 2009 - 10:15am
tags:
Alkermes, Amylin, Vivitrol
Biotech Stocks Hot Right Now, Ho-Hum in the Long Run
WSJ Online
Wednesday, November 18, 2009 - 10:13am
tags:
biotech, Talecris, deCODE Genetics
NicOx to Sell New Shares as FDA Agrees to Review Arthritis Drug
Bloomberg
Wednesday, November 18, 2009 - 9:33am
tags:
FDA, arthritis, stock offering, NicOx, naproxcinod
Another Genzyme Drug Goes Kaboom
TheStreet.com
Wednesday, November 18, 2009 - 9:09am
tags:
Genzyme, kidney disease, Renvela, APB
Drugmakers' Differences: Analyst's Toolkit
TheStreet.com
Wednesday, November 18, 2009 - 9:06am
tags:
Pfizer, Merck, GSK, Sanofi
Vivus Erection Drug Worked Within 30 Minutes in Study
Bloomberg
Wednesday, November 18, 2009 - 9:05am
tags:
erectile dysfunction, Vivus, Avanafil
Mead Johnson: This Poison Pill Aids Investors
NY Times, NY
Wednesday, November 18, 2009 - 9:03am
tags:
poison pill, investors, Bristol-Myers Squibb, Mead Johnson
Answering The Vytorin Question
Forbes
Wednesday, November 18, 2009 - 9:02am
tags:
Merck, Zetia, Vytorin, Abbott Laboratories, Niaspan, cholesterol
Crestor Cuts Cardiovascular Problems In Women
WSJ Online
Tuesday, November 17, 2009 - 5:27pm
tags:
AstraZeneca, women, Crestor, statins, JUPITER
Titan Pharmaceuticals: Finally Reaching Its Potential
Seeking Alpha
Tuesday, November 17, 2009 - 5:22pm
tags:
Titan
BioCryst hopes to raise $57M with stock offering
Bizjournals.com
Tuesday, November 17, 2009 - 4:07pm
tags:
Biocryst, stock offering
Oxigene's developing cancer treatment meets safety goals in midstage study
Yahoo/AP
Tuesday, November 17, 2009 - 2:17pm
tags:
Oxigene, drug studies, lung cancer, Zybrestat
Vaccines on horizon for AIDS, Alzheimer's, herpes
Yahoo/AP
Tuesday, November 17, 2009 - 2:16pm
tags:
AIDS, Alzheimer's disease, herpes, vaccines, GSK, Crucell, AstraZeneca
Brilinta bests Plavix in trial
Fierce Biotech
Tuesday, November 17, 2009 - 2:15pm
tags:
Plavix, Brilinta, AstraZeneca, Sanofi, Bristol-Myers Squibb
A Big Upgrade for Sanofi-Aventis
Motley Fool
Tuesday, November 17, 2009 - 11:35am
tags:
Sanofi
Merck dodged Zetia bullet, analysts say
Fierce Pharma
Tuesday, November 17, 2009 - 11:34am
tags:
Zetia, Merck, Abbott Laboratories, Niaspan, cholesterol
Drug-price outcry threatens to derail reform
Fierce Pharma
Tuesday, November 17, 2009 - 11:33am
tags:
healthcare reform, drug prices
Human Genome's ABthrax Faces FDA Delay
Yahoo/Zacks.com
Tuesday, November 17, 2009 - 11:21am
tags:
ABthrax, anthrax, vaccines, FDA, Human Genome Sciences

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.